登录新浪财经APP 搜索【信披】查看更多考评等级 债券代码：127088 债券简称：赫达转债 山东赫达集团股份有限公司关于第三期股票期权与限制性股票激励计划第一个解除限售期解除 限售股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： 1、公司第三期股票期权与限制性股票激励计划（以下简称"本次激励计划"、"本激励计划"或"《激励计 划》"）第一个解除限售期符合解除限售条件的激励对象共110人，可解除限售的限制性股票数量为 2,480,000股，占目前公司总股本348,136,913股的0.7124%。 2、本次解除限售的限制性股票的上市流通日为2025年11月28日。 山东赫达集团股份有限公司（以下简称"公司"）于2025年10月20日召开第九届董事会第二十七次会议， 审议通过《关于第三期股票期权与限制性股票激励计划第一个行权期行权条件成就的议案》及《关于第 三期股票期权与限制性股票激励计划第一个解除限售期解除限售条件成就的议案》，具体内容详见公司 于2025年10月21日在巨潮资讯网披露的《关于第三期股票期权与限制性股票激 ...

Core Viewpoint - The company has decided to cancel part of the stock options and invalidate some unvested restricted stocks from its third stock option and restricted stock incentive plan due to unmet performance targets for the year 2024 [4][6][7] Group 1: Decision Process and Approval - On May 27, 2024, the company held a board meeting to approve the draft of the third stock option and restricted stock incentive plan, along with its management measures [1][2] - The plan was publicly announced and no objections were raised during the internal review period [2][3] - The plan was approved in a shareholders' meeting on June 12, 2024, and the stock options were granted on June 21, 2024 [3][4] Group 2: Cancellation and Invalidity Details - The company will cancel 1,364,000 stock options and invalidate 580,000 shares of restricted stock from the first vesting period due to failure to meet the performance target of a 15% net profit growth for 2024 [4][5] - The performance assessment period for the incentive plan spans from 2024 to 2026, with annual evaluations [5] Group 3: Impact on the Company - The cancellation of stock options and invalidation of restricted stocks will not have a substantial impact on the company's financial status or operational results [6][7] - The management team's stability and the continuation of the incentive plan will remain unaffected [6][7] Group 4: Committee and Supervisory Opinions - The board's nomination, compensation, and assessment committee confirmed that the cancellation and invalidation are compliant with relevant regulations and do not harm the interests of the company or its shareholders [6][7] - The supervisory board also agreed with the decision, affirming its legality and compliance with applicable laws [7]